Discuss This Drug

Zanamivir

CHEBI:CHEBI_50663

Chemical Information

Molecular Formula
C12H20N4O7
Molecular Mass
332.30996
Charge
0
SMILES
[H][C@]1(OC(=C[C@H](NC(N)=N)[C@H]1NC(C)=O)C(O)=O)[C@H](O)[C@H](O)CO
InChI
InChI=1S/C12H20N4O7/c1-4(18)15-8-5(16-12(13)14)2-7(11(21)22)23-10(8)9(20)6(19)3-17/h2,5-6,8-10,17,19-20H,3H2,1H3,(H,15,18)(H,21,22)(H4,13,14,16)/t5-,6+,8+,9+,10+/m0/s1
InChIKey
ARAIBEBZBOPLMB-UFGQHTETSA-N

Alternative Names

  • (2R,3R,4S)-3-(acetylamino)-4-carbamimidamido-2-[(1R,2R)-1,2,3-trihydroxypropyl]-3,4-dihydro-2H-pyran-6-carboxylic acid
  • 4-guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid
  • 4-guanidino-Neu5Ac2en
  • 5-(acetylamino)-2,6-anhydro-4-carbamimidamido-3,4,5-trideoxy-D-glycero-D-galacto-non-2-enonic acid
  • 5-acetamido-2,6-anhydro-3,4,5-trideoxy-4-guanidino-D-glycero-D-galacto-non-2-enonic acid
  • 5-acetamido-2,6-anhydro-4-carbamimidamido-3,4,5-trideoxy-D-glycero-D-galacto-non-2-enonic acid
  • GANA
  • Relenza
  • zanamivir
  • ZANAMIVIR

Treatment Applications

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

DRON_00010000
69722
oboInOwl#hasDbXref
Wikipedia:Zanamivir
core#notation
CHEBI:50663

Additional References

Wikipedia:Zanamivir

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

oboInOwl#hasOBONamespace
chebi_ontology
DRON_00010000
69722
oboInOwl#hasDbXref
Wikipedia:Zanamivir
oboInOwl#hasAlternativeId
CHEBI:46607
oboInOwl#id
CHEBI:50663
core#notation
CHEBI:50663
generic_name
zanamivir
active_ingredient_name
ZANAMIVIR
rxcui
759473
product_type
BULK INGREDIENT
marketing_category
BULK INGREDIENT
listing_expiration_date
20241231
dosage_form
POWDER
route
RESPIRATORY (INHALATION)
active_ingredient_strength
1 kg/kg
pharm_class_epc
Neuraminidase Inhibitor [EPC]
pharm_class
Neuraminidase Inhibitors [MoA]
pharm_class_moa
Neuraminidase Inhibitors [MoA]
marketing_start_date
19990922
package_marketing_start_date
19990922
labeler_name
GlaxoSmithKline LLC
manufacturer_name
GlaxoSmithKline LLC
nui
N0000175436
product_ndc
0173-0681
spl_id
70cc37eb-e91d-41b1-b061-d0b1a17e5358
package_ndc
0173-0681-22
package_description
5 PACKAGE in 1 CARTON (0173-0681-22) / 4 POWDER in 1 PACKAGE
brand_name
RELENZA
brand_name_base
RELENZA
application_number
NDA021036
unii
L6O3XI777I
spl_set_id
d7c3bcc3-0c0d-4068-fd80-88cf54a376ef
oboInOwl#inSubset
http://purl.obolibrary.org/obo/chebi#3_STAR
RO_0000087
http://purl.obolibrary.org/obo/CHEBI_52425
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class
has_treatment
http://purl.obolibrary.org/obo/DOID_4492
rdf-schema#range
https://w3id.org/def/predibionto#has_drug_102551
rdf-schema#domain
https://w3id.org/def/predibionto#has_side_effect26991
owl#annotatedSource
t238756
owl#someValuesFrom
t633965